Analysts Set Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Target Price at $21.45

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) has been assigned a consensus rating of “Hold” from the twelve brokerages that are currently covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating and five have assigned a buy rating to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $21.4545.

Several brokerages have recently commented on SBRA. UBS Group decreased their price objective on Sabra Healthcare REIT from $22.00 to $21.00 and set a “neutral” rating for the company in a report on Wednesday, July 8th. Wall Street Zen upgraded Sabra Healthcare REIT from a “sell” rating to a “hold” rating in a research note on Sunday, June 28th. Citigroup lowered Sabra Healthcare REIT from a “buy” rating to a “neutral” rating and reduced their target price for the company from $24.00 to $19.00 in a research report on Monday, June 22nd. Raymond James Financial assumed coverage on Sabra Healthcare REIT in a research note on Wednesday, June 17th. They issued an “underperform” rating for the company. Finally, Truist Financial raised Sabra Healthcare REIT from a “hold” rating to a “buy” rating and set a $22.00 price target for the company in a report on Wednesday, July 8th.

Sabra Healthcare REIT Trading Down 0.2%

NASDAQ SBRA opened at $20.11 on Friday. The company has a quick ratio of 4.72, a current ratio of 4.72 and a debt-to-equity ratio of 0.96. The firm has a market cap of $5.07 billion, a PE ratio of 31.92, a price-to-earnings-growth ratio of 1.50 and a beta of 0.65. The company has a 50 day moving average price of $19.60 and a 200 day moving average price of $19.74. Sabra Healthcare REIT has a 52 week low of $17.17 and a 52 week high of $21.28.

Sabra Healthcare REIT (NASDAQ:SBRA) last posted its earnings results on Wednesday, April 29th. The real estate investment trust reported $0.16 EPS for the quarter, meeting analysts’ consensus estimates of $0.16. Sabra Healthcare REIT had a net margin of 19.22% and a return on equity of 5.60%. The company had revenue of $211.74 million during the quarter, compared to analysts’ expectations of $209.20 million. During the same quarter in the prior year, the company posted $0.37 earnings per share. Sabra Healthcare REIT’s revenue for the quarter was up 20.9% compared to the same quarter last year. Sabra Healthcare REIT has set its FY 2026 guidance at 1.550-1.590 EPS. As a group, sell-side analysts forecast that Sabra Healthcare REIT will post 1.5 EPS for the current fiscal year.

Sabra Healthcare REIT Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, May 29th. Investors of record on Friday, May 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. The ex-dividend date of this dividend was Friday, May 15th. Sabra Healthcare REIT’s dividend payout ratio (DPR) is presently 190.48%.

Institutional Trading of Sabra Healthcare REIT

A number of institutional investors have recently bought and sold shares of the stock. Rothschild Investment LLC raised its holdings in shares of Sabra Healthcare REIT by 164.6% in the fourth quarter. Rothschild Investment LLC now owns 1,429 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 889 shares during the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Sabra Healthcare REIT by 97.7% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,445 shares of the real estate investment trust’s stock worth $27,000 after buying an additional 714 shares during the period. Strengthening Families & Communities LLC purchased a new stake in shares of Sabra Healthcare REIT during the fourth quarter valued at $29,000. Versant Capital Management Inc grew its holdings in shares of Sabra Healthcare REIT by 70.0% during the second quarter. Versant Capital Management Inc now owns 1,465 shares of the real estate investment trust’s stock valued at $29,000 after buying an additional 603 shares during the last quarter. Finally, Danske Bank A S acquired a new position in shares of Sabra Healthcare REIT in the 3rd quarter valued at $30,000. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc (NASDAQ: SBRA) is a real estate investment trust that acquires, owns and operates net?lease healthcare properties. Its diversified portfolio spans senior housing communities, skilled nursing and rehabilitation centers, outpatient medical facilities, medical office buildings, hospitals and life science properties. Sabra structures long?term, triple?net lease agreements with healthcare operators, providing stable rental income streams while allowing tenants to focus on patient care and operational excellence.

Serving a broad spectrum of care segments, Sabra’s tenants include both regional and national providers of assisted living, independent living, memory care, post?acute rehabilitation and research and development laboratories.